2 Cash-Producing Stocks Worth Your Attention and 1 Facing Headwinds

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.

Cash flow is valuable, but it’s not everything - StockStory helps you identify the companies that truly put it to work. That said, here are two cash-producing companies that reinvest wisely to drive long-term success and one that may face some trouble.

One Stock to Sell:

Edgewell Personal Care (EPC)

Trailing 12-Month Free Cash Flow Margin: 1.8%

Boasting brands such as Banana Boat, Schick, and Skintimate, Edgewell Personal Care (NYSE:EPC) sells personal care products in the skin and sun care, shave, and feminine care categories.

Why Should You Dump EPC?

1. Absence of organic revenue growth over the past two years suggests it may have to lean into acquisitions to drive its expansion
2. Overall productivity fell over the last year as its plummeting sales were accompanied by a decline in its operating margin
3. 6× net-debt-to-EBITDA ratio makes lenders less willing to extend additional capital, potentially necessitating dilutive equity offerings

Edgewell Personal Care is trading at $21.14 per share, or 9.8x forward P/E. Read our free research report to see why you should think twice about including EPC in your portfolio.

Two Stocks to Watch:

O'Reilly (ORLY)

Trailing 12-Month Free Cash Flow Margin: 8.8%

Serving both the DIY customer and professional mechanic, O’Reilly Automotive (NASDAQ:ORLY) is an auto parts and accessories retailer that sells everything from fuel pumps to car air fresheners to mufflers.

Why Is ORLY a Good Business?

1. Locations open for at least a year are seeing increased demand as same-store sales have averaged 3.8% growth over the past two years
2. Excellent operating margin of 19.5% highlights the efficiency of its business model
3. Stellar returns on capital showcase management’s ability to surface highly profitable business ventures

At $95.10 per share, O'Reilly trades at 29.2x forward P/E. Is now the right time to buy? Find out in our full research report, it’s free.

Elevance Health (ELV)

Trailing 12-Month Free Cash Flow Margin: 1.6%

Formerly known as Anthem until its 2022 rebranding, Elevance Health (NYSE:ELV) is one of America's largest health insurers, serving approximately 47 million medical members through its network-based managed care plans.

Why Are We Positive On ELV?

1. Annual revenue growth of 10.3% over the last five years was above the sector average and underscores its products and services value to customers
2. Enormous revenue base of $197.6 billion gives it leverage over plan holders and advantageous reimbursement terms with healthcare providers
3. ROIC punches in at 27.3%, illustrating management’s expertise in identifying profitable investments

Elevance Health’s stock price of $288.55 implies a valuation ratio of 11x forward P/E. Is now a good time to buy? See for yourself in our full research report, it’s free.

Stocks We Like Even More

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.